Detection of prostate cancer in symptomatic patients with prostate specific antigen between 4 and 10 ng/ml;DETECTION DU CANCER PROSTATIQUE CHEZ LES PATIENTS SYMPTOMATIQUES AYANT DES TAUX D'ANTIGENE PROSTATIQUE SPECIFIQUE SERIQUE ENTRE 4 ET 10 NG/ML

Presse Medicale

Volumn 25, Issue 7, 1996, Pages 272-276

  Ravery, V ^a,b   Schmid, H P ^a   Billebaud, T ^a   Toublanc, M ^a   Boccon Gibod, Li ^a   Hermieu, J F ^a   Delmas, V ^a   Boccon Gibod, L ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PROSTATE BIOPSY; PROSTATE CANCER; ADENOCARCINOMA; BLOOD; CANCER STAGING; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; PROSTATECTOMY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0030599813     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vallancien G. Prapotnich D, Veillon B. Brisset JM. André-Bougaran J. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination J Urol 1991; 146:1308-12
2. Voisin E, Platon E, Rivain T, Duco F, Diagnostic précoce du cancer de la prostate par toucher rectal, dosage du PSA et échographie endorectale. Corrélations avec le diagnostic morphologique dans 200 cas consécutifs Prog Urol (Paris) 1992, 2:973-9.
3. Brawer MK, Beatie J, Wener MH, Vessella RL, Preston SD, Lange PH. Screening for prostatic caicinoma with prostate specific antigen : results of the second year. J Urol 1993; 150:106-9
4. Brawer MK, Chetner MP, Beatie J. Buchner DM, Vessela RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen J Urol 1992; 147 841-5
5. Kirby RS, Kirby MG, Feneley MR. McNicholas T, McLean A, Webb J. Screening for carcinoma of the prostate: a GP based study Br J Urol 1994, 74 64-71
6. Oesterling JE, Jacobsen SJ. Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270:860-4.
7. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen, J Urol 1992; 147:817-21
8. Lepor H, Owens RS, Rogenes V. Kuhn E Detection of prostate cancer in males with prostatism. Prostate 1994; 25.132-40.
9. Ramon J, Boccon-Gibod L, Billebaud T et al Prostate-specific antigen density. a means to enhance detection of prostate cancer. Eur Urol 1994; 25:288-94.
10. Vessella RL, Lange PH Issues in the assessment of PSA immunoassays. Urol clin North Am 1993; 20:607-19.
11. Babaian RJ, Miyashita H, Evans RB, Ramirez El The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer, relationship to gland volume and age J Urol 1992 ; 147:837-40
12. Carter HB, Pearson JD, Metter EJ et al Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA 1992; 267:2215.
13. Partin AW, Yoo J, Carter HB et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 1993; 150:110-14
14. Andriole GL. Screening for prostate cancer based on prostate-specific antigen Eur Urol 1995, 27 6-8.
15. Labrie F, Dupont A, Suburu R et al Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992, 147:846-52.